Medicare Enrolled

Dr. Alejandro Pino, MD

Pulmonary Disease · Encinitas, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
326 SANTA FE DR STE 100, Encinitas, CA 92024
7602308994
In practice since 2015 (10 years)
NPI: 1457748089 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pino from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pino? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pino

Dr. Alejandro Pino is a pulmonary disease specialist in Encinitas, CA, with 10 years of NPI registration. Based on federal Medicare data, Dr. Pino performed 1,064 Medicare services across 712 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pino received a total of $6,364 from 21 pharmaceutical and/or device companies across 233 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pino is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 10 years in practice ▲ Top 35% volume in CA $6,364 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,064
Medicare services
Top 35% in CA for pulmonary disease
712
Unique beneficiaries
$115
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~106 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
385 $98 $362
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
223 $171 $812
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
110 $97 $380
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
89 $143 $594
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
79 $151 $558
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
40 $68 $265
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
37 $47 $173
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
37 $47 $182
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
30 $30 $149
New patient office visit, complex (60-74 min) 20 $168 $656
Telephone medical discussion, 21-30 minutes
A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone.
14 $68 $337
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,364
Total received (2021-2024)
Avg $1,591/year across 4 years
Top 24% in CA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
21
Companies
233
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,957 (93.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$407 (6.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,532
2023
$1,926
2022
$1,418
2021
$488

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$700
Regeneron Healthcare Solutions, Inc.
$241
Amgen Inc.
$236
GlaxoSmithKline, LLC.
$202
Boehringer Ingelheim Pharmaceuticals, Inc.
$200
GENZYME CORPORATION
$195
Actelion Pharmaceuticals US, Inc.
$177
Stryker Corporation
$140
Insmed, Inc.
$80
SANOFI-AVENTIS U.S. LLC
$79
Janssen Pharmaceuticals, Inc
$73
Grifols USA, LLC
$64
Mallinckrodt Hospital Products Inc.
$56
Philips North America LLC
$42
Optinose US, Inc.
$25
Bayer Healthcare Pharmaceuticals Inc.
$23
Top 3 companies account for 46.5% of 2024 payments
All-time payments by company (2021-2024) ›
AstraZeneca Pharmaceuticals LP
$1,767
GlaxoSmithKline, LLC.
$636
Boehringer Ingelheim Pharmaceuticals, Inc.
$610
Amgen Inc.
$572
Actelion Pharmaceuticals US, Inc.
$530
Ethicon Inc.
$488
GENZYME CORPORATION
$418
Regeneron Healthcare Solutions, Inc.
$269
Stryker Corporation
$218
Janssen Pharmaceuticals, Inc
$187
SANOFI-AVENTIS U.S. LLC
$136
Mallinckrodt Hospital Products Inc.
$131
Grifols USA, LLC
$80
Insmed, Inc.
$80
ABBVIE INC.
$56
Takeda Pharmaceuticals U.S.A., Inc.
$49
Philips North America LLC
$42
Baxter Healthcare
$28
Optinose US, Inc.
$25
Bayer Healthcare Pharmaceuticals Inc.
$23
Pulmonx Corporation
$20
Top 3 companies account for 47.3% of all-time payments
Associated products mentioned in payments ›
(O58) Sleep Respiratory Care Und · ACTHAR · AIRSUPRA · AVYCAZ · Adempas · Arikayce · BREZTRI · CHARTIS CATHETER · CLAW II · DUPIXENT · FASENRA · GLASSIA · Hillrom - Life 2000 Ventilation System · Monarch Platform · N/A · NUCALA · OFEV · OPSUMIT · Prolastin-C Liquid · STIOLTO RESPIMAT · SYMBICORT · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · UPTRAVI · XARELTO · Xhance
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pulmonary disease specialist in Encinitas?
Compare pulmonary diseases in the Encinitas area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
110
Per 100K population
3.4
County median income
$102,285
Nearest hospital
SCRIPPS MEMORIAL HOSPITAL - ENCINITAS
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Pino is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Pino experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Pino performed 385 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pino receive payments from pharmaceutical companies?
Yes. Dr. Pino received a total of $6,364 from 21 companies across 233 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pino's costs compare to other pulmonary diseases in Encinitas?
Dr. Pino's average Medicare payment per service is $115. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pino) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →